| D00539 | |
| D number | D00539 |
| Classification | Drug |
| Name | Ethosuximide (JP17/USP/INN); Zarontin (TN) |
| Component | - |
| Formula | C7H11NO2 |
| Exact mass | 141.079 |
| Mol weight | 141.1677 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Neuropsychiatric agent DG02033 Succinimide antiepileptics Other DG01575 Calcium channel blocker DG01573 Calcium channel T type blocker Cyp substrate DG01633 CYP3A substrate |
| Remark | Same as: C07505 Therapeutic category: 1139 ATC code: N03AD01 Chemical group: DG02416 |
| Activity | - |
| Disease | - |
| Comment | Succinimide derivative |
| Target | CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854] |
| Metabolism | Enzyme: CYP3A4 [HSA:1576] |
| Interaction | |
| Other DBs | CAS: 77-67-8 PubChem: 7847605 ChEBI: 4887 ChEMBL: CHEMBL696 DrugBank: DB00593 LigandBox: D00539 NIKKAJI: J1.477J |
| KCF data | - |